Lenz Therapeutics
(NASDAQ) LENZ
Lenz Therapeutics Financials at a Glance
Market Cap
$184.68M
Revenue (TTM)
$20.99M
Net Income (TTM)
-$109.00M
EPS (TTM)
-$3.59
P/E Ratio
-1.64
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$5.90
Volume
1,028,493.556
Open
$5.79
Price
$5.90
Volume
1,028,493.556
Open
$5.79
Previous Close
$5.89
Daily Range
$5.76 - $6.06
52-Week Range
$5.23 - $50.40
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$5.90
Volume
1,028,493.556
Open
$5.79
Previous Close
$5.89
Daily Range
$5.76 - $6.06
52-Week Range
$5.23 - $50.40
Estimated Earnings Date
Jul 29, 2026
LENZ News
LENZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lenz Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
152
CEO
Evert B. Schimmelpennink
Website
www.lenz-tx.comHeadquarters
Solana Beach, CA 92014, US
LENZ Financials
Key Financial Metrics (TTM)
Gross Margin
91.16%
Operating Margin
-563.83%
Net Income Margin
-519.30%
Return on Equity
-46.82%
Return on Capital
-31.96%
Return on Assets
-39.99%
Earnings Yield
-60.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$184.68M
Shares Outstanding
31.35M
Volume
1.03M
Avg. Volume
785.45K
Financials (TTM)
Gross Profit
$19.13M
Operating Income
-$118.34M
EBITDA
-$108.13M
Operating Cash Flow
-$86.70M
Capital Expenditure
-$735.00K
Free Cash Flow
-$87.44M
Cash & ST Invst.
$258.39M
Total Debt
$673.00K
Lenz Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.90M
N/A
Gross Profit
$714.00K
+2083.3%
Gross Margin
37.56%
N/A
Market Cap
$184.68M
N/A
Market Cap/Employee
$30.78M
N/A
Employees
6
N/A
Net Income
-$41.49M
-183.8%
EBITDA
-$41.38M
-183.7%
Quarterly Fundamentals
Total Cash
$258.39M
+33.2%
Total Debt
$673.00K
-43.1%
Accounts Receivable
$343.00K
N/A
Inventory
$3.50M
N/A
Long Term Debt
$237.00K
-64.8%
Short Term Debt
$436.00K
-14.3%
Return on Assets
-39.99%
N/A
Return on Invested Capital
-47.96%
N/A
Free Cash Flow
-$33.60M
-107.9%
Operating Cash Flow
-$33.58M
-109.2%